Document is current

Article History

Received: 10 January 2017

Accepted: 19 April 2017

First Online: 1 June 2017

Competing Interests

: All authors have completed the Unified Competing Interest form at ExternalRef removed (available on request from the corresponding author) and declare that (1) No authors have support from any company for the submitted work; (2) HD has relationships (Travel/accommodations expenses covered/reimbursed) with Astrazeneca who might have an interest in the work submitted in the previous 3 years; JMB has relationships (Travel/accommodations expenses covered/reimbursed) with Otsuka, Lundbeck, Janssen, and Lilly who might have an interest in the work submitted in the previous 3 years; BF has been a consultant for E. Lilly, BMS, Servier, SANOFI, GSK, HRA, Roche, Boeringer Ingelheim, Bayer, Almirall, Allergan, Stallergene, Genzyme, Pierre Fabre, Astrazeneca, Novartis, Janssen, Astellas, Biotronik, Daiichi-Sankyo, Gilead, MSD, Lundbeck, Stallergene, Actelion, UCB, Otsuka, Grunenthal, ViiV; GR has relationships (Travel/accommodations expenses covered/reimbursed) with Lundbeck, Otsuka and Janseen who might have an interest in the work submitted in the previous 3 years; MR has relationships (Travel/accommodations expenses covered/reimbursed) with Astrazeneca, Orphan Europe and Janssen who might have an interest in the work submitted in the previous 3 years; J.S. and S.B. have no relationship with any company that might have an interest in the work submitted in the previous 3 years; DD has relationships (board membership or consultancy or travel/accommodation expenses covered/reimbursed) with Servier, Lilly, Janssen-Cilag, Otsuka, Lundbeck, Astra Zeneca who might have an interest in the work submitted in the previous 3 years; NF has relationships (Travel/accommodations expenses covered/reimbursed) with Servier, BMS, Lundbeck and Janssen who might have an interest in the work submitted in the previous 3 years; (3) No author’s spouse, partner, or children have any financial relationships that could be relevant to the submitted work; and (4) none of the authors has any non-financial interests that could be relevant to the submitted work.